Leading the way in GI Healthcare

We are proud to be a national leader in research and technology in the field of gastrointestinal disease. At GIA, our goal is to advance the treatment and prevention of gastrointestinal illness and provide the best state-of-the-art health care for our patients.

In order to meet this goal, we are constantly reviewing new technologies and treatments. We have been recognized throughout the country for pioneering the use of photodynamic therapy, radiofrequency ablation and mucosal resection for the treatment of Barrett’s esophagus. In many cases, these therapies can eliminate the need for surgical removal of the esophagus.

We have also been among the first to test the Given capsule, a swallowable “pill” providing video pictures of the small intestine to help visualize and detect disorders of the gastrointestinal tract.

Leading the way in gastrointestinal research and development is not new to GIA. We have long been on the cutting-edge of developing ways to improve patient care. Our work in outpatient endoscopy led to the development of the first licensed and certified endoscopic ambulatory surgery center in the U.S.

In order to help advance the body of knowledge in gastroenterology throughout our industry, we constantly share our techniques and results with our fellow GI practices. We publish our findings in peer-reviewed journal articles. And we have been one of the co-founders of GI Roundtable, a national two-day conference bringing together more than 250 of the nation’s top gastroenterologists and practice managers to share information on improving health care and strengthening quality measures.

Measuring performance to advance quality care is gaining national attention and again we are setting the standard. Our quality assurance programs provide measurable outcomes that allow us to continually track our performance quality to ensure we are providing the best patient care possible. We consistently rate excellent and our performance measures far exceed the national average.

You can rest assured you will be well cared for by nationally recognized team and caring staff. Through research, technology and quality patient care we are setting the standard in gastrointestinal health care at Gastrointestinal Associates.

About the author:

Dr. Bergein “Gene” Overholt, co-founder and president of Gastrointestinal Associates, is a nationally recognized gastroenterologist who developed the flexible fiberoptic sigmoidoscope and colonoscope. Overholt’s work on the fiberoptic sigmoidoscope earned him the prestigious Schindler Award from the American Society for Gastrointestinal Endoscopy.